Posts | Comments | Contact

Rosetta Genomics Ltd. (NASD:ROSG) Seasonal Chart

Rosetta Genomics Ltd. (NASD:ROSG) Seasonality

ROSG Relative to the S&P 500
ROSG Relative to the S&P 500

ROSG Relative to the Sector
ROSG Relative to the Sector

Monthly Seasonal Rosetta Genomics Ltd. (NASD:ROSG)

Seasonal Chart Analysis

Analysis of the Rosetta Genomics Ltd. (NASD:ROSG) seasonal charts above shows that a Buy Date of December 31 and a Sell Date of April 9 has resulted in a geometric average return of 21.74% above the benchmark rate of the S&P 500 Total Return Index over the past 9 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 9 years by an average of 77.13% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 9 years of data is available for shares of ROSG, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Rosetta Genomics Ltd is engaged
in the development and commercialization of new diagnostic products based on a recently discovered group of genes known as microRNAs. MicroRNAs are naturally expressed, or produced, using instructions encoded in DNA.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...